SAB Biotherapeutics, Inc. (SABS) Earnings
NASDAQ·Healthcare·Biotechnology
$3.08
+1.65%
Mkt Cap $267.50M
EPS — Estimate vs Actual
Mkt Cap
$267.50M
P/E
5.14
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$2.46
NASDAQ·Healthcare·Biotechnology
$3.08
+1.65%
Mkt Cap $267.50M
Mkt Cap
$267.50M
P/E
5.14
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$2.46